Chlamydia pneumoniae and cerebrovascular disease;Chlamydia pneumoniae y enfermedad cerebrovascular

Revista de Neurologia

Volumn 32, Issue 3, 2001, Pages 201-206

  Linares Palomino, J ^a   Gutierrez J ^a   Lopez Espada C ^a   Ros, E ^a   Moreno, J ^a   Perez T ^a   Rodriguez M ^a   Maroto, M C ^a  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

Author keywords

Antibody; Atherosclerosis; Carotid stenosis; Case control studies; Chlamydia pneumoniae; Polymerase chain reaction

Indexed keywords

BACTERIAL DNA; FIBRINOGEN; IMMUNOGLOBULIN G ANTIBODY;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BACTERIAL INFECTION; CAROTID ARTERY; CAROTID ARTERY OBSTRUCTION; CAROTID ARTERY SURGERY; CEREBROVASCULAR DISEASE; CHLAMYDOPHILA PNEUMONIAE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MALE; POLYMERASE CHAIN REACTION; SEROPREVALENCE; VARICOSIS;

EID: 0035245213     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3203.2000420     Document Type: Article

References (55)

1. Diseases of the arteries
2. Atherosclerosis: The consequence of infection with a herpes virus
3. Preceding infection as an important risk factor for ischaemic brain infarction in young and middle aged patients
4. Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms
5. Serologic evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction
6. Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease
7. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study
8. Circulating immune completes containing chlamydial lipopolysaccharide in acute myocardial infarction
9. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques
10. Chlamydia pneumoniae and atherosclerosis
11. The relation between C. pneumoniae and atherosclerosis
12. Chlamydia pneumoniae y su relación con la arteriosclerosis humana
13. North American Symptomatic Carotid Endarterectomy Trial (NASCET)
14. Asymptomatic Carotid Atherosclerotic Study (ACAS)
15. Detection of C. Pneumoniae by polymerase chain reaction
16. Smoking is a potential confounder of the C. pneumoniae coronary artery disease association
17. C. pneumoniae: Risk factors for seropositivity and association with coronary heart disease
18. Chlamydia pneumoniae antibody response in patients with acute myocardial infarction and their follow-up
19. Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not
20. Coronary angioplasty induces rise in Chlamydia pneumoniae-specific antibodies
21. Serological evidence of Chlamydia pneumoniae lipopolysaccharide antibodies in atherosclerosis of various vascular regions
22. Past infection by Chlamydiapneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) Study Investigators
23. Association of chlamydial infection with cerebrovascular disease
24. Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: The West Birmingham Stroke Project
25. Demonstration of viable Chlamydiapneumoniae in atherosclerotic plaques of carotid arteries by reverse transcriptase polymerase chain reaction
26. Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease: A prospective study in middle-aged to elderly men with treated hypertension
27. Chlamydiapneumoniae infection and early asymptomatic carotid atherosclerosis
28. Lack of association between seropositivity to Chlamydia pneumoniae and carotid atherosclerosis
29. Chlamydia pneumoniae infection and incident coronary heart disease: The Atherosclerosis Risk in Communities Study
30. Endovascular presence of viable C. pneumoniae is a common phenomenon in coronary artery disease
31. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery
32. Failure to detect Chlamydia pneumioniae in atherosclerotic plaques of Australian patients
33. Atherosclerosis-an inflammatory disease
34. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery
35. Endovascular presence of Chlamydia pneumoniae in patients with hemodynamically effective carotid artery stenosis
36. Endovascular presence of Chlamydia pneumoniae DNA is a generalized phenomenon in atherosclerotic vascular disease
37. Detection of Chlamydia pneumoniae DNA in atheromatous tissues by polymerase chain reaction
38. Low prevalence of Chlamydia pneumoniae in atherectomy specimens from patients with coronary heart disease
39. Distribution of Chlamydia pneumoniae infection in the atherosclerotic carotid artery
40. Multiple infections in carotid atherosclerotic plaques
41. Detection of Chlamydia pneumoniae-reactive T lymphocytes in human atherosclerotic plaques of carotid artery
42. Distribution of Chlamydia pneumoniae infection in the atherosclerotic carotid artery
43. Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications
44. Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: Evaluation of the innocent bystander hypothesis
45. Poor correlation between microimmunofluorescence serology and polymerase chain reaction for detection of vascular Chlamydia pneumoniae infection in coronary artery disease patients
46. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors
47. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen
48. Expression of adhesion molecules on endothelial cells stimulated by Chlamydia pneumoniae
49. Reactivation of Chlamydia pneumoniae infection in mice by cortisone treatment
50. Chlamydia pneumoniae antibody response in patients with acute myocardial infarction and their follow-up
51. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells and aortic artery smooth muscle cells
52. Infection of human endothelial cells with Chlamydia pneumoniae stimulates transendothelial migration of neutrophils and monocytes
53. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines
54. Chlamydiapneumoniae reactive T lymphocytes in the walls of abdominal aortic aneurysms
55. Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages